Beyond Air, Inc. (XAIR) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Beyond Air, Inc. on February 5, 2025. The filing addresses a critical corporate governance matter regarding the Company's continued listing status on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes and Listing Status
- Initial Deficiency: On August 8, 2024, Nasdaq notified the Company of a failure to meet the minimum bid price requirement of $1.00 per share for 30 consecutive business days (June 25, 2024, through August 7, 2024).
- Compliance Extension: On February 5, 2025, Nasdaq granted the Company an additional 180-day compliance period, extending the deadline to August 4, 2025.
- Basis for Extension: The extension was granted because the Company met all other initial listing requirements, including the market value of publicly held shares, and submitted a written notice of intent to cure the deficiency, potentially via a reverse stock split.
- Current Status: The Company's common stock remains listed and traded on the Nasdaq Capital Market pending compliance.
Outlook, Risks, and Contingencies
Management has indicated an intention to cure the bid price deficiency during the second compliance period, potentially by effecting a reverse stock split. To utilize a reverse stock split for compliance, it must be completed no later than ten business days prior to the August 4, 2025 expiration date.
Risks: There is no assurance that the Company will regain compliance. If the closing bid price does not reach $1.00 for ten consecutive business days, or if a reverse stock split is not successfully implemented in time, Nasdaq will notify the Company of delisting. The Company retains the right to appeal a delisting determination to a Hearings Panel.
Investor Verification Checklist
- Verify the current trading price of XAIR to assess proximity to the $1.00 threshold.
- Monitor for shareholder meeting notices or proxy statements regarding a potential reverse stock split.
- Review the attached press release (Exhibit 99.1) for additional management commentary on the cure plan.
- Track the Company's progress toward the August 4, 2025 compliance deadline.